Audio Link of Concall held on May 29, 2026
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Natco Pharma has filed a regulatory disclosure informing exchanges that the transcript of its Q4 FY25-26 earnings conference call held on May 29, 2026 is now available. The company has enclosed the transcript copy and noted it is also accessible on their website. This filing complies with SEBI Listing Regulation 30 requirements for timely disclosure of investor relations material. The actual content of management commentary, guidance, or strategic updates discussed during the call is not included in this filing — investors must access the transcript separately to review the discussion.
This is a procedural filing ensuring investors can access the Q4 earnings call transcript. The stock impact will depend on what was discussed during the call, which requires reviewing the transcript separately.